Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

82 results about "Posterior capsule" patented technology

The posterior capsule is the clear layer of tissue that supports the intraocular lens, which is implanted into the eye at the time of cataract surgery. Over time after cataract surgery, the posterior capsule may lose its clarity.

Bag-in-the-lens intraocular lens with removable optic and capsular accommodation ring

InactiveUS20070123981A1Intraocular lensOphthalmologyLens epithelial cell proliferation
This invention describes an intraocular lens (IOL) design with a removable optic, which can be inserted in and removed from a haptic device. In this haptic the anterior and posterior capsules are sealed in order to have a perfect control over the lens epithelial cell proliferation which is thereby restricted to the peripheral part of the capsular bag. Additionally, a ring caliper is described as new surgical device to allow a precise sizing and centration of the anterior capsulorhexis. The removable optic allows repeatable correction of the eye focusing over time in case the optical parameters of the eye have changed due to a variety of factors. By separating the optic part from the haptic part, the optic part can easily be manufactured in any shape matching the optical errors of the eye, including the optical aberrations. The optic part can be manufactured out of any biomaterial restoring ocular accommodation. The optic part may include prismatic, astigmatic or magnification correction to improve visual performance. The optic part may consist of or include an electronic device for the purpose of artificial vision. In order to further assist the accommodative capabilities of the implant a capsular accommodation ring of specific biomechanical properties is inserted in the capsular equator.
Owner:TASSIGNON MARIE JOSE B

Methods and Devices for Preventing or Delaying Posterior Capsule Opacification

InactiveUS20110082543A1Prevents and minimizes and delays formationMinimize formationPharmaceutical delivery mechanismEye treatmentChemical MoietyBovine serum albumin
Several methods for preventing, minimizing, or delaying the incidence of posterior capsule opacification are provided. A first method involves chemically activating the surface of an implantable ocular device, such as an intraocular lens or a capsular tension ring, by grafting a chemical moiety onto the surface of the device, covalently attaching a non-cytotoxic inhibitor compound to the chemical moiety to produce an inhibitor implantable ocular device, and implanting this inhibitor implantable ocular device into the capsular bag of an eye of a patient during extracapsular cataract surgery. Appropriate inhibitor compounds include RGD mimetics, RGD peptides, and flavonoids. A second method involves surface modifying the exterior surface of a capsular tension ring by covalently attaching a mitotic inhibitor, preferably a conjugate of methotrexate and a bovine serum albumin, and implanting this inhibitor tension ring into the capsular bag of an eye of a patient during extracapsular cataract surgery. A third method involves surface modifying the exterior surface of a capsular tension ring by coating or grafting the exterior surface with a charged polyethylamine and implanting this inhibitor tension ring into the capsular bag of an eye of a patient during extracapsular cataract surgery. An implantable ocular device according to the invention, such as an intraocular lens or a capsular tension ring, contains a substrate with a chemical moiety grafted thereon and a non-cytotoxic inhibitor compound covalently bonded to the chemical moiety or contains a substrate modified with a mitotic inhibitor or charged polyethylamine. The inhibitor devices inhibits proliferation and migration of lens epithelial cells on the posterior capsule of the eye of the patient, thereby preventing, minimizing, or delaying the onset of posterior capsule opacification.
Owner:CLEO COSMETIC & PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products